- Home
- BYSI vs CBUS Comparison
BYSI vs CBUS Comparison
Compare BYSI & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYSI
- CBUS
- Stock Information
- Founded
- BYSI 2010
- CBUS 2010
- Country
- BYSI United States
- CBUS United States
- Employees
- BYSI N/A
- CBUS N/A
- Industry
- BYSI Biotechnology: Pharmaceutical Preparations
- CBUS Agricultural Chemicals
- Sector
- BYSI Health Care
- CBUS Industrials
- Exchange
- BYSI Nasdaq
- CBUS Nasdaq
- Market Cap
- BYSI 79.0M
- CBUS 86.7M
- IPO Year
- BYSI 2017
- CBUS 2017
- Fundamental
- Price
- BYSI $2.18
- CBUS $1.33
- Analyst Decision
- BYSI
- CBUS Strong Buy
- Analyst Count
- BYSI 0
- CBUS 2
- Target Price
- BYSI N/A
- CBUS $21.25
- AVG Volume (30 Days)
- BYSI 47.9K
- CBUS 765.4K
- Earning Date
- BYSI 11-13-2025
- CBUS 11-13-2025
- Dividend Yield
- BYSI N/A
- CBUS N/A
- EPS Growth
- BYSI N/A
- CBUS N/A
- EPS
- BYSI N/A
- CBUS N/A
- Revenue
- BYSI N/A
- CBUS $4,846,000.00
- Revenue This Year
- BYSI N/A
- CBUS $17.67
- Revenue Next Year
- BYSI N/A
- CBUS $63.43
- P/E Ratio
- BYSI N/A
- CBUS N/A
- Revenue Growth
- BYSI N/A
- CBUS 63.66
- 52 Week Low
- BYSI $0.98
- CBUS $1.20
- 52 Week High
- BYSI $3.44
- CBUS $6.10
- Technical
- Relative Strength Index (RSI)
- BYSI 60.33
- CBUS 43.14
- Support Level
- BYSI $1.86
- CBUS $1.20
- Resistance Level
- BYSI $2.21
- CBUS $1.37
- Average True Range (ATR)
- BYSI 0.15
- CBUS 0.10
- MACD
- BYSI 0.02
- CBUS -0.03
- Stochastic Oscillator
- BYSI 77.68
- CBUS 26.53
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.